Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Simona Soverini, Luana Bavaro, Caterina De Benedittis, Margherita Martelli, Alessandra Iurlo, Nicola Orofino, Simona Sica, Federica Sorà, Francesca Lunghi, Fabio Ciceri, Sara Galimberti, Claudia Baratè, Massimiliano Bonifacio, Luigi Scaffidi, Fausto Castagnetti, Gabriele Gugliotta, Francesco Albano, Antonella Vita Russo Rossi, Fabio Stagno, Francesco di Raimondo, Mariella D’Adda, Eros di Bona, Elisabetta Abruzzese, Gianni Binotto, Rosaria Sancetta, Marzia Salvucci, Isabella Capodanno, Mariella Girasoli, Sabrina Coluzzi, Immacolata Attolico, Caterina Musolino, Elisabetta Calistri, Mario Annunziata, Monica Bocchia, Stefania Stella, Anna Serra, Santa Errichiello, Giuseppe Saglio, Fabrizio Pane, Paolo Vigneri, Flavio Mignone, Maria Antonella Laginestra, Stefano Aldo Pileri, Antonio Percesepe, Elena Tenti, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli

Blood (2020) 135 (8): 534–541.

https://doi.org/10.1182/blood.2019002969

Published: 2020

Includes: Supplemental data

Journal Articles

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

Emilia Giugliano, Roberta Lorenzatti, Dr., Enrico Marco Gottardi, Dr., Chiara Sammartino, Dr., Roberta Toja, Francesca Crasto, Dr, Alessandro Volpengo, Dr, Cristina Fantino, Dr, Filomena Daraio, PhD, Anna Serra, Dr, Francesca Carnuccio, Dr, Giuseppe Saglio, MD PhD, Angelo Guerrasio, MD

Blood (2017) 130 (Supplement 1): 5097.

https://doi.org/10.1182/blood.V130.Suppl_1.5097.5097

Published: 2017

Journal Articles

What's Next in CML - a Prospective Study Evaluating Sanger Sequencing and Next Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain (KD) Mutation Screening

Simona Soverini, PhD, Luana Bavaro, Caterina De Benedittis, PhD, Margherita Martelli, Stefania Stella, PhD, Paolo Vigneri, MD PhD, Alessandra Iurlo, MD PhD, Nicola Orofino, MD, Simona Sica, MD, Federica Sorà, MD, Sara Galimberti, PhD MD, Claudia Baratè, MD PhD, Francesco Albano, MD, Antonella Russo Rossi, MD, Fabio Ciceri, MD, Francesca Lunghi, MD, Fausto Castagnetti, MD, Gabriele Gugliotta, MD PhD, Gianantonio Rosti, MD, Elena Tenti, PhD, Fabio Stagno, MD PhD, Elisabetta Novella, PhD, Eros Di Bona, MD, Massimiliano Bonifacio, MD, Elisabetta Abruzzese, MD PhD, Marzia Salvucci, MD, Mariella D'Adda, MD, Rosaria Sancetta, MD, Elisabetta Calistri, MD, Monica Bocchia, Isabella Capodanno, MD, Giuseppina Spinosa, MD, Maria Antonella Laginestra, PhD, Santa Errichiello, PhD, Anna Serra, Dr, Francesca Carnuccio, Dr, Sabrina Coluzzi, PhD, Mario Annunziata, MD, Caterina Musolino, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD PhD, Michele Baccarani, MD, Michele Cavo, MD, Giovanni Martinelli, MD

Blood (2017) 130 (Supplement 1): 248.

https://doi.org/10.1182/blood.V130.Suppl_1.248.248

Published: 2017

Journal Articles

The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy

Simona Soverini, Caterina De Benedittis, Stefania Stella, Anna Serra, Francesca Carnuccio, Santa Errichiello, PhD, Luana Bavaro, Fausto Castagnetti, MD, Alessandra Iurlo, MD, Nicola Orofino, MD, Federica Sorà, Simona Sica, Sara Galimberti, MD PhD, Claudia Baratè, Federica Mottadelli, Margherita Martelli, Elisabetta Novella, Eros Di Bona, MD, Giorgina Specchia, Francesco Albano, Elisabetta Abruzzese, MD, Fabio Ciceri, MD, Francesca Lunghi, MD, Carmen Fava, MD, Giovanna Rege Cambrin, MD, Luigia Luciano, Massimo Breccia, MD, Clementina Caracciolo, MD, Marco Santoro, Francesco Di Raimondo, MD, Gabriele Gugliotta, Cristina Papayannidis, MD PhD, Giovanni Cazzaniga, Manuela Mancini, Rosaria Sancetta, Renato Bassan, Caterina Musolino, MD, Giuseppina Spinosa, Silvana Franca Capalbo, Mario Annunziata, MD, Michele Cavo, MD, Gianantonio Rosti, Michele Baccarani, Paolo Vigneri, Giuseppe Saglio, MD, Fabrizio Pane, Giovanni Martinelli

Blood (2016) 128 (22): 3097.

https://doi.org/10.1182/blood.V128.22.3097.3097

Published: 2016

Journal Articles

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Jaspal S Kaeda, PhD, Christian Oberender, Daniel Neuman, Theo Kim, MD, Ken I Mills, PhD, Anna Serra, PhD, Philipp Hemmati, MD, Regina Schleede, Tim Overkamp, Frauke Ringel, PhD, Thomas Pretzsch, Seval Turkmen, MD, Michaela Schwarz, MD, Renate Arnold, MD, Bernd Dörken, MD, Philipp le Coutre, MD

Blood (2012) 120 (21): 1449.

https://doi.org/10.1182/blood.V120.21.1449.1449

Published: 2012

Journal Articles

Design and Application of a Novel PNA Probe for the Detection At Single Cell Level of JAK2 V617F Mutation

Daniela Cilloni, MD, Valentina Rosso, PhD, Davide Torti, MD, Francesca Carnuccio, PhD, Anna Serra, PhD, Paolo Nicoli, MD, Valentina Gaidano, MD, Valentina Campia, PhD, Elisabetta Signorino, PhD, Chiara Calabrese, PhD, Sonia Carturan, PhD, Alessandra Favole, PhD, Giuseppe Saglio, MD, Francesco Frassoni, Enrico Bracco, PhD

Blood (2012) 120 (21): 1761.

https://doi.org/10.1182/blood.V120.21.1761.1761

Published: 2012

Journal Articles

Detection of an Unbalanced Ratio Between WT1 Isoforms in Acute Myeloid Leukemia and Its Correlation with Molecular Abnormalities.

Chiara Calabrese, PhD, Gian Matteo Pica, MD, Enrico Bracco, PhD, Anna Serra, PhD, Francesca Carnuccio, PhD, Sonia Carturan, PhD, Valentina Campia, PhD, Chiara Ghiggi, PhD, Fabio Guolo, PhD, Angelo Michele Carella, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Francesco Frassoni, Giuseppe Saglio, MD, Daniela Cilloni, MD

Blood (2012) 120 (21): 2500.

https://doi.org/10.1182/blood.V120.21.2500.2500

Published: 2012

Journal Articles

Increased MSI2 expression Is Associated with Aggressive CML and AML

Blood (2011) 118 (21): 2516.

https://doi.org/10.1182/blood.V118.21.2516.2516

Published: 2011

Journal Articles

09:00–09:05Escalated Dasatinib Dose up to 60 Mg O.D. in Elderly Patients with Chronic Myeloid Leukemia in Late Chronic Phase Resistant to or Intolerant of Imatinib-12 Months Follow-up

Francesco Iuliano, Antonio Russo, Maria Cristina Caroleo, Filomena Conforti, Anna Serra

Blood (2008) 112 (11): 4283.

https://doi.org/10.1182/blood.V112.11.4283.4283

Published: 2008

Journal Articles

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Thomas Lion, Marcel Tilanus, Hélène Cavé, Mark Lawler, Anna Serra, Andrea Biondi, Jacques van Dongen, Marcos González, Gisela Barbany, Eddy Roosnek, Colin Steward, Peter Bader

Blood (2006) 108 (11): 621.

https://doi.org/10.1182/blood.V108.11.621.621

Published: 2006

Journal Articles

Absence of Spred1, a Negative Regulator of Ras/MAPK Pathway, as a Mechanism Responsible for the Constitutive Activation of RTK Mediated Signalling in Acute Leukemias.

Daniela Cilloni, MD, PhD, Enrico Bracco, PhD, Ilaria Defilippi, PhD, Francesca Messa, PhD, Sonia Carturan, PhD, Daniela Di Giovanni, PhD, Francesca Arruga, PhD, Valentina Rosso, PhD, Renata Catalano, PhD, Emanuela Messa, MD, Alessandro Morotti, MD, Anna Serra, PhD, Giuseppe Saglio, MD

Blood (2005) 106 (11): 2287.

https://doi.org/10.1182/blood.V106.11.2287.2287

Published: 2005

Journal Articles

Correlation of JAK2 Mutation and PRV-1 and WT1 Transcript Amount in Myeloproliferative Disorders.

Anna Serra, PhD, Sonia Carturan, PhD, Enrico Gottardi, PhD, Francesca Arruga, PhD, Francesca Messa, PhD, Paola Sterpone, PhD, Ilaria Defilippi, PhD, Valentina Rosso, PhD, Renata Catalano, PhD, Giovanni Martinelli, MD, Francesco Iuliano, MD, Giuseppe Saglio, MD, Daniela Cilloni, MD, PhD

Blood (2005) 106 (11): 1206.

https://doi.org/10.1182/blood.V106.11.1206.1206

Published: 2005

Journal Articles

Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome

Jürgen Groet, Claire Mulligan, Monica Spinelli, Anna Serra, Suzanne McElwaine, Finbarr E. Cotter, Franca Dagna-Bricarelli, Giuseppe Saglio, Giuseppe Basso, Dean Nizetic

Blood (2005) 106 (5): 1887–1888.

https://doi.org/10.1182/blood-2005-03-1071

Published: 2005

Journal Articles

Idiopathic Hypereosinophilic Syndrome (HES) with FIP1L1-PDGFRA Rearrangement Can Be Effectively Treated with Imatinib.

Blood (2004) 104 (11): 1504.

https://doi.org/10.1182/blood.V104.11.1504.1504

Published: 2004

NARROW

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

What's Next in CML - a Prospective Study Evaluating Sanger Sequencing and Next Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain (KD) Mutation Screening

The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Design and Application of a Novel PNA Probe for the Detection At Single Cell Level of JAK2 V617F Mutation

Detection of an Unbalanced Ratio Between WT1 Isoforms in Acute Myeloid Leukemia and Its Correlation with Molecular Abnormalities.

Increased MSI2 expression Is Associated with Aggressive CML and AML

09:00–09:05Escalated Dasatinib Dose up to 60 Mg O.D. in Elderly Patients with Chronic Myeloid Leukemia in Late Chronic Phase Resistant to or Intolerant of Imatinib-12 Months Follow-up

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Absence of Spred1, a Negative Regulator of Ras/MAPK Pathway, as a Mechanism Responsible for the Constitutive Activation of RTK Mediated Signalling in Acute Leukemias.

Correlation of JAK2 Mutation and PRV-1 and WT1 Transcript Amount in Myeloproliferative Disorders.

Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome

Idiopathic Hypereosinophilic Syndrome (HES) with FIP1L1-PDGFRA Rearrangement Can Be Effectively Treated with Imatinib.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only